How pharmacies should adopt value- and performance-based payment models and offer DIR fee reductions for pharmacists’ and their patients’ benefit.
Eyad Farah
Advertisement
Articles by Eyad Farah
Advertisement
Latest Updated Articles
Preparing Pharmacy for Performance-Based ReimbursementPublished: February 3rd 2020 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What Health Plans Should Ask For in Their PBM Contracts If They Want Transparency | AMCP Nexus 2025
2
Automated Prior Authorization Speeds Approval of GLP-1 Therapies | AMCP Nexus 2025
3
Nonfactor agents for hemophilia prophylaxis: A Q&A with Steven Pipe, M.D.
4
Nonfactor Therapies for Hemophilia: Current Evidence, Clinical Relevance and Cost Considerations
5
